State Street’s RxSight RXST Stock Holding History

State Street’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.1M	Buy	851,512 +50,189	+6%	+$303K	﹤0.01%	3102
2026 Q1	$4.94M	Sell	801,323 -47,654	-6%	-$396K	﹤0.01%	2971
2025 Q4	$8.85M	Buy	848,977 +24,833	+3%	+$249K	﹤0.01%	2712
2025 Q3	$7.41M	Sell	824,144 -92,071	-10%	-$808K	﹤0.01%	2806
2025 Q2	$11.9M	Buy	916,215 +17,546	+2%	+$264K	﹤0.01%	2483
2025 Q1	$22.7M	Buy	898,669 +7,870	+0.9%	+$234K	﹤0.01%	2070
2024 Q4	$30.6M	Buy	890,799 +73,128	+9%	+$3.3M	﹤0.01%	1971
2024 Q3	$40.4M	Buy	817,671 +62,349	+8%	+$3.19M	﹤0.01%	1810
2024 Q2	$45.4M	Buy	755,322 +84,039	+13%	+$4.8M	﹤0.01%	1723
2024 Q1	$34.6M	Sell	671,283 -32,684	-5%	-$1.6M	﹤0.01%	1917
2023 Q4	$28.4M	Buy	703,967 +6	+0%	+$176	﹤0.01%	2008
2023 Q3	$19.6M	Buy	703,961 +254,081	+56%	+$7.58M	﹤0.01%	2186
2023 Q2	$13M	Buy	449,880 +81,959	+22%	+$1.82M	﹤0.01%	2502
2023 Q1	$6.14M	Buy	367,921 +73,869	+25%	+$1.04M	﹤0.01%	2916
2022 Q4	$3.73M	Buy	294,052 +3,045	+1%	+$37K	﹤0.01%	3170
2022 Q3	$3.49M	Buy	291,007 +3,765	+1%	+$51.7K	﹤0.01%	3233
2022 Q2	$4.04M	Buy	287,242 +135,935	+90%	+$1.79M	﹤0.01%	3197
2022 Q1	$1.87M	Buy	151,307 +43,623	+41%	+$524K	﹤0.01%	3593
2021 Q4	$1.21M	Buy	107,684 +17,307	+19%	+$208K	﹤0.01%	3767
2021 Q3	$1.15M	Buy	+90,377	New	+$1.24M	﹤0.01%	3750

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street's RXST Position: Q2 2026 in Review

State Street increased its RxSight (RXST) stake by 6.3% in Q2 2026, buying an estimated $303K and bringing the position to 851,512 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3102.

State Street first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $45.4M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

State Street held 851,512 shares of RxSight worth $4.1M as of Q2 2026.
State Street bought 50,189 RxSight shares in Q2 2026, an estimated $303K.
RxSight made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3102 holding.
State Street first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
State Street's RxSight position peaked at $45.4M in Q2 2024.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.